Cardiovascular Disease in Anabolic Androgenic Steroid Users
AAS use is associated with a substantially increased risk of cardiovascular disease in a large cohort with a long follow-up period.
Authors
- Kim Dalhoff (ORCID: https://orcid.org/0000-0002-5548-6381)
- Jón Trærup Andersen (ORCID: https://orcid.org/0000-0003-0169-1328)
- Josefine Windfeld‐Mathiasen (ORCID: https://orcid.org/0000-0001-6821-4898)
- Michael Asger Andersen (ORCID: https://orcid.org/0000-0001-9729-9974)
- Flemming Javier Olsen (ORCID: https://orcid.org/0000-0001-9511-8375)
- Karl Sebastian Johansson (ORCID: https://orcid.org/0000-0003-2125-4555)
- Henrik Horwitz (ORCID: https://orcid.org/0000-0001-6436-1567)
- Tor Biering‐Sørensen (ORCID: https://orcid.org/0000-0003-4209-2778)
- Ida M. Heerfordt (ORCID: https://orcid.org/0000-0002-6130-875X)
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Frederiksberg Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
Publication Details
- Journal
- Circulation
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1161/circulationaha.124.071117
- Citations
- 42
- Primary Topic
- Hormonal and reproductive studies
- Type
- article
- Field-Weighted Citation Impact
- 54.39